{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:59:44Z","timestamp":1778864384727,"version":"3.51.4"},"reference-count":93,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34357","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:41:56Z","timestamp":1720532516000},"page":"e34357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genome-wide expression analysis in a Fabry disease human podocyte cell line"],"prefix":"10.1016","volume":"10","author":[{"given":"Sarah","family":"Snanoudj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Derambure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thi","family":"Hai Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Lesueur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9na\u00efg","family":"Abily-Donval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Marret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Mardinoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumeya","family":"Bekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-2678","authenticated-orcid":false,"given":"Abdellah","family":"Tebani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020271","article-title":"Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions","volume":"11","author":"Kok","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2024.e34357_bib2","series-title":"Essentials of Glycobiology","first-page":"129","article-title":"Glycosphingolipids","author":"Schnaar","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e34357_bib3","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","article-title":"Fabry's disease: classification as a sphingolipidosis and partial characterization of a novel glycolipid","volume":"238","author":"Sweeley","year":"1963","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biology13010034","article-title":"Lysosomal dysfunction: connecting the dots in the landscape of human diseases","volume":"13","author":"Uribe-Carretero","year":"2024","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41580-019-0185-4","article-title":"Lysosomes as dynamic regulators of cell and organismal homeostasis","volume":"21","author":"Ballabio","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e34357_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41580-023-00676-x","article-title":"Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology","volume":"25","author":"Settembre","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e34357_bib7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/eurheartj\/ehae148","article-title":"Anderson\u2013Fabry disease management: role of the cardiologist","volume":"45","author":"Pieroni","year":"2024","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib8","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2024.e34357_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pediatrneurol.2016.07.001","article-title":"Fabry disease: a disorder of childhood onset","volume":"64","author":"Schiffmann","year":"2016","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2027852","article-title":"Fabry disease \u2013 a multisystemic disease with gastrointestinal manifestations","volume":"14","author":"Lenders","year":"2022","journal-title":"Gut Microb."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e34357_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34357_bib14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/biom11070951","article-title":"Newborn screening for Fabry disease in northeastern Italy: results of five years of experience","volume":"11","author":"Gragnaniello","year":"2021","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34357_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","article-title":"Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A)","volume":"30","author":"Hwu","year":"2009","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib16","first-page":"157","article-title":"Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"Desnick","year":"1973","journal-title":"J. Lab. Clin. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34357_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejmg.2015.10.014","article-title":"Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: an alternative methodology","volume":"58","author":"Caudron","year":"2015","journal-title":"Eur. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1399-0004.2011.01689.x","article-title":"Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene","volume":"81","author":"Ferri","year":"2012","journal-title":"Clin. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/jmedgenet-2017-104863","article-title":"Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study","volume":"55","author":"Arends","year":"2018","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34357_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jmedgenet-2016-104178","article-title":"Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study","volume":"54","author":"Hughes","year":"2017","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34357_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/HCO.0000000000000308","article-title":"Fabry disease: will markers of early disease enable early treatment and better outcomes?","volume":"31","author":"Hughes","year":"2016","journal-title":"Curr. Opin. Cardiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107585","article-title":"An expert consensus on the recommendations for the use of biomarkers in Fabry disease","volume":"139","author":"Burlina","year":"2023","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2017.07.002","article-title":"Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease","volume":"123","author":"Nowak","year":"2018","journal-title":"Mol. Genet. Metabol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34357_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182379","article-title":"Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: analysis of prognostic factors","volume":"12","author":"Arends","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41436-020-00968-z","article-title":"Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease","volume":"23","author":"Bichet","year":"2021","journal-title":"Genet. Med."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e34357_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810088","article-title":"Pathogenesis and molecular mechanisms of anderson-fabry disease and possible new molecular addressed therapeutic strategies","volume":"22","author":"Tuttolomondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34357_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091555","article-title":"Omics-based strategies in precision medicine: toward a paradigm shift in inborn errors of metabolism investigations","volume":"17","author":"Tebani","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/ETLS20210244","article-title":"Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities","volume":"6","author":"Ahmed","year":"2022","journal-title":"Emerg Top Life Sci"},{"key":"10.1016\/j.heliyon.2024.e34357_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics data integration, interpretation, and its application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinf. Biol. Insights"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13023-020-01376-x","article-title":"A scoping review and proposed workflow for multi-omic rare disease research","volume":"15","author":"Kerr","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.heliyon.2024.e34357_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.590842","article-title":"Multi-omics approaches to improve mitochondrial disease diagnosis: challenges, advances, and perspectives","volume":"7","author":"Labory","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2024.e34357_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.adgen.2015.11.004","article-title":"Integrative analysis of multi-omics data for discovery and functional studies of complex human diseases","volume":"93","author":"Sun","year":"2016","journal-title":"Adv. Genet."},{"issue":"572","key":"10.1016\/j.heliyon.2024.e34357_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34357_bib34","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1002\/mco2.315","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000488121","article-title":"Fabry nephropathy: an evidence-based narrative review","volume":"43","author":"Del Pino","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib36","doi-asserted-by":"crossref","first-page":"F1015","DOI":"10.1152\/ajprenal.00283.2016","article-title":"Characterization and phosphoproteomic analysis of a human immortalized podocyte model of Fabry disease generated using CRISPR\/Cas9 technology","volume":"311","author":"Pereira","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1\u20133","key":"10.1016\/j.heliyon.2024.e34357_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-5793(02)02491-2","article-title":"Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry","volume":"515","author":"Mills","year":"2002","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib38","first-page":"157","article-title":"Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes: \u03b1-Galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"Desnick","year":"1973","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib40","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34357_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.heliyon.2024.e34357_bib42","series-title":"R: a Language and Environment for Statistical Computing","author":"Team","year":"2020"},{"key":"10.1016\/j.heliyon.2024.e34357_bib43","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ije\/dyq191","article-title":"Reprinted: the proof and measurement of association between two things (2010)","volume":"39","author":"Spearman","year":"1904","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward's hierarchical agglomerative clustering method: which algorithms implement Ward's criterion?","volume":"31","author":"Murtagh","year":"2014","journal-title":"J. Classif."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34357_bib45","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/bioinformatics\/btm069","article-title":"pcaMethods\u2014a bioconductor package providing PCA methods for incomplete data","volume":"23","author":"Stacklies","year":"2007","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34357_bib46","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1073\/pnas.0406811102","article-title":"Uncovering transcriptional regulation of metabolism by using metabolic network topology","volume":"102","author":"Patil","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"50","key":"10.1016\/j.heliyon.2024.e34357_bib47","doi-asserted-by":"crossref","first-page":"E11874","DOI":"10.1073\/pnas.1807305115","article-title":"Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes","volume":"115","author":"Bidkhori","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e34357_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbiomolbio.2023.08.002","article-title":"Computational approaches for modeling and structural design of biological systems: a comprehensive review","volume":"185","author":"Gayathiri","year":"2023","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BST20210145","article-title":"Computational approaches to understand transcription regulation in development","volume":"51","author":"van der Sande","year":"2023","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.heliyon.2024.e34357_bib50","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00415-020-10044-w","article-title":"Oxidative stress biomarkers in Fabry disease: is there a room for them?","volume":"267","author":"Simoncini","year":"2020","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol. Genet. Metabol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34357_bib52","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1083\/jcb.147.7.1431","article-title":"RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules","volume":"147","author":"Kedersha","year":"1999","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34357_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075127","article-title":"T-cell intracellular antigen (TIA)-proteins deficiency in murine embryonic fibroblasts alters cell cycle progression and induces autophagy","volume":"8","author":"Sanchez-Jimenez","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34357_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13084","article-title":"Endoplasmic reticulum-stress and unfolded protein response-activation in immune-mediated necrotizing myopathy","volume":"32","author":"Preusse","year":"2022","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molcel.2004.05.005","article-title":"The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells","volume":"14","author":"Brumbaugh","year":"2004","journal-title":"Mol. Cell"},{"issue":"29","key":"10.1016\/j.heliyon.2024.e34357_bib57","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1038\/onc.2008.48","article-title":"hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress","volume":"27","author":"Gehen","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e34357_bib58","first-page":"2122","article-title":"Glomerular proteomic profiles in the NZB\/W F1 hybrid mouse model of lupus nephritis","volume":"25","author":"Xue","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol. Genet. Metabol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34357_bib60","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/01.ASN.0000121781.89599.16","article-title":"Signaling danger: toll-like receptors and their potential roles in kidney disease","volume":"15","author":"Anders","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34357_bib61","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","article-title":"Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy","volume":"62","author":"Thurberg","year":"2002","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34357_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34357_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103644","article-title":"Therapeutic potential of glutaminyl cyclases: current status and emerging trends","author":"Coimbra","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11033-022-07931-y","article-title":"Trends in extracellular matrix biology","volume":"50","author":"Kyriakopoulou","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34357_bib65","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jcp.24810","article-title":"The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45beta2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway","volume":"230","author":"Della Noce","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e34357_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1749-6632.1990.tb17915.x","article-title":"The structure and function of type VII collagen","volume":"580","author":"Burgeson","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34357_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113659","article-title":"Lyso-Gb3 increases alphavbeta3 integrin gene expression in cultured human podocytes in Fabry nephropathy","volume":"9","author":"Trimarchi","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34357_bib69","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1681\/ASN.2019050497","article-title":"Accumulation of globotriaosylceramide in podocytes in Fabry nephropathy is associated with progressive podocyte loss","volume":"31","author":"Najafian","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"20","key":"10.1016\/j.heliyon.2024.e34357_bib70","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/hmg\/ddv291","article-title":"Lyso-Gb3 activates Notch1 in human podocytes","volume":"24","author":"Sanchez-Ni\u00f1o","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e34357_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0009-8981(98)00169-7","article-title":"Urinary excretion of the vitronectin receptor (integrin alpha V beta 3) in patients with Fabry disease","volume":"279","author":"Utsumi","year":"1999","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34357_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260135","article-title":"MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis","volume":"16","author":"Shin","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34357_bib73","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.emboj.7600532","article-title":"Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis","volume":"24","author":"Zhang","year":"2005","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34357_bib74","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2011.06.007","article-title":"Higher apoptotic state in Fabry disease peripheral blood mononuclear cells.: effect of globotriaosylceramide","volume":"104","author":"De Francesco","year":"2011","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/jhg.2015.123","article-title":"Unravelling the mechanism of action of enzyme replacement therapy in Fabry disease","volume":"61","author":"Ko","year":"2016","journal-title":"J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34357_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168346","article-title":"Urinary podocyte loss is increased in patients with Fabry disease and correlates with clinical severity of Fabry nephropathy","volume":"11","author":"Fall","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib77","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4161\/auto.6.5.11943","article-title":"Autophagosome maturation is impaired in Fabry disease","volume":"6","author":"Chevrier","year":"2010","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063506","article-title":"Dysregulated autophagy contributes to podocyte damage in Fabry's disease","volume":"8","author":"Liebau","year":"2013","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.heliyon.2024.e34357_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111339","article-title":"Alpha-galactosidase a deficiency in Fabry disease leads to extensive dysregulated cellular signaling pathways in human podocytes","volume":"22","author":"Jehn","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34357_bib80","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1007\/s12035-015-9456-z","article-title":"Cellular signature of SIL1 depletion: disease pathogenesis due to alterations in protein composition beyond the ER machinery","volume":"53","author":"Roos","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34357_bib81","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34357_bib82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb2303","article-title":"The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal","volume":"13","author":"Zhao","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"302","key":"10.1016\/j.heliyon.2024.e34357_bib83","doi-asserted-by":"crossref","first-page":"rs15","DOI":"10.1126\/scisignal.2004712","article-title":"Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions","volume":"6","author":"Couzens","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.heliyon.2024.e34357_bib84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biocel.2013.11.021","article-title":"STRIPAK complexes: structure, biological function, and involvement in human diseases","volume":"47","author":"Hwang","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib85","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/15548627.2021.2002546","article-title":"The complex interplay between ULK1 and protein phosphatases in autophagy regulation","volume":"18","author":"Siva Sankar","year":"2022","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib86","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.3892\/mmr.2016.5010","article-title":"YAP-mediated crosstalk between the Wnt and Hippo signaling pathways","volume":"22","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34357_bib87","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s42003-023-04813-2","article-title":"Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation","volume":"6","author":"Messelodi","year":"2023","journal-title":"Commun. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34357_bib88","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.3390\/ijms24065246","article-title":"Fabry disease and central nervous system involvement: from big to small, from brain to synapse","volume":"24","author":"Cort\u00e9s-Saladelafont","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34357_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157782","article-title":"Accumulation of \u03b1-synuclein mediates podocyte injury in Fabry nephropathy","volume":"133","author":"Braun","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34357_bib90","doi-asserted-by":"crossref","first-page":"F1015","DOI":"10.1152\/ajprenal.00283.2016","article-title":"Characterization and phosphoproteomic analysis of a human immortalized podocyte model of Fabry disease generated using CRISPR\/Cas9 technology","volume":"311","author":"Pereira","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34357_bib91","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.ymgme.2018.12.269","article-title":"Proteomic profiling of engineered human immortalized podocyte cell model of Fabry disease","volume":"126","author":"Neto","year":"2019","journal-title":"Mol. Genet. Metabol."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e34357_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111339","article-title":"\u03b1-Galactosidase a deficiency in Fabry disease leads to extensive dysregulated cellular signaling pathways in human podocytes","volume":"22","author":"Jehn","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e34357_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trsl.2023.02.006","article-title":"Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease","volume":"258","author":"Tebani","year":"2023","journal-title":"Transl. Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34357_bib94","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/jpm11090898","article-title":"Parsing Fabry disease metabolic plasticity using metabolomics","volume":"11","author":"Ducatez","year":"2021","journal-title":"J. Personalized Med."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410388X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410388X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:40:07Z","timestamp":1773841207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402410388X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":93,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S240584402410388X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34357","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome-wide expression analysis in a Fabry disease human podocyte cell line","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34357"}}